Purple Biotech GAAP EPS of -$0.27 misses by $0.07

Nov. 08, 2022 9:17 AM ETPurple Biotech Ltd. (PPBT)By: Pranav Ghumatkar, SA News Editor
  • Purple Biotech press release (NASDAQ:PPBT): Q3 GAAP EPS of -$0.27 misses by $0.07.
  • As of September 30, 2022, the Company had a total amount of $35.7 million in cash, cash equivalent and short and long term deposits.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.